Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Advanced human iPSC-based preclinical model for Parkinson’s disease with optogenetic alpha-synuclein aggregation

Cell stem cell(2023)10.1016/j.stem.2023.05.015Source: DataRank Database

Advanced human iPSC-based preclinical model for Parkinson’s disease with optogenetic alpha-synuclein aggregation is a research paper published in Cell stem cell (2023). On theSindex it has a DataRank of 0. It has been cited 60 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access60 citations

Download PDF

Cite:

Linked data & code

rrid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 9.54)OA: bronzeTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Eun A.,Sin Ho Kweon ORCID,Bo Am Seo ORCID,Han Seok Ko,Yohan Oh ORCID

Live enrichment

PubMed:37339636 PMC:PMC10829432 OpenAlex:https://openalex.org/W4381186258

NIA NIH HHS

Grant: R03 AG063101

NINDS NIH HHS

Grant: R01 NS093213

NINDS NIH HHS

Grant: R01 NS107404

FWCI

9.54

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S1934590923002114/pdf

publisherhttp://www.cell.com/article/S1934590923002114/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1934590923002114?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1934590923002114?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.stem.2023.05.015

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsPhotoreceptor and optogenetics research

MeSH Terms

HumansNeuroblastomaParkinson Diseasealpha-SynucleinInduced Pluripotent Stem CellsDopaminergic NeuronsOptogenetics

Keywords

Alpha-synucleinOptogeneticsBiologyParkinson's diseaseNeuroscienceDiseaseInduced pluripotent stem cellAlpha (finance)Internal medicineGeneticsMedicineGeneProtein aggregationDopaminergic neuronsParkinson’s DiseaseHuman Pluripotent Stem CellOrganoidΑ-synuclein Preformed FibrilsΑ-syn PffsOpto-alpha-synuclein

Sustainable Development Goals

SDG 0: Good health and well-being